Cargando…

Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study

The combination of the direct-acting antivirals, simeprevir (SMV) and sofosbuvir (SOF), was the first highly efficacious interferon-free combination for treating patients with hepatitis C virus (HCV), and was widely used in Italy as a result. The aim of this study was to evaluate effectiveness and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaeta, Giovanni Battista, Aghemo, Alessio, Menzaghi, Barbara, D’Offizi, Gianpiero, Giorgini, Alessia, Hasson, Hamid, Brancaccio, Giuseppina, Palma, Maria, Termini, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076166/ https://www.ncbi.nlm.nih.gov/pubmed/29979400 http://dx.doi.org/10.1097/MD.0000000000011307

Ejemplares similares

The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center
por: Montalbano, Marzia, et al.
Publicado: (2020)

Clinical Characteristics of Acute Hepatitis E and Their Correlation with HEV Genotype 3 Subtypes in Italy
por: Minosse, Claudia, et al.
Publicado: (2020)

Phylogenetic and Phylodynamic Analysis of Delta Strains Circulating in Italy
por: Salichos, Leonidas, et al.
Publicado: (2023)

Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
por: Minosse, Claudia, et al.
Publicado: (2021)

Timely HAART initiation may pave the way for a better viral control
por: Paci, Paola, et al.
Publicado: (2011)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
por: Paci, Paola, et al.
Publicado: (2009)

High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of liver transplant recipients in central Italy
por: Visco-Comandini, Ubaldo, et al.
Publicado: (2022)

Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study
por: Alam, Imtiaz, et al.
Publicado: (2016)

Simeprevir for the treatment of hepatitis C virus infection
por: Izquierdo, Laure, et al.
Publicado: (2014)

In vitro susceptibility of human Blastocystis subtypes to simeprevir
por: Mossallam, Shereen F., et al.
Publicado: (2021)

Simeprevir restores the anti-Staphylococcus activity of polymyxins
por: Wu, Yuan, et al.
Publicado: (2023)

Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma
por: El Sharkasy, Mona E., et al.
Publicado: (2022)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
por: Baiocchini, Andrea, et al.
Publicado: (2019)

Publisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
por: Baiocchini, Andrea, et al.
Publicado: (2020)

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment
por: Ouwerkerk-Mahadevan, Sivi, et al.
Publicado: (2015)

Long-Term Follow-Up of Acute Hepatitis B: New Insights in Its Natural History and Implications for Antiviral Treatment
por: Menzo, Stefano, et al.
Publicado: (2018)

Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger?
por: Del Nonno, Franca, et al.
Publicado: (2021)

Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review
por: Fusco, Francesco Maria, et al.
Publicado: (2019)

In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2
por: Sberna, Giuseppe, et al.
Publicado: (2022)

Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center
por: Berardi, Giammauro, et al.
Publicado: (2020)

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C
por: Sarkar, Souvik, et al.
Publicado: (2015)

A simeprevir-inducible molecular switch for the control of cell and gene therapies
por: Chin, Stacey E., et al.
Publicado: (2023)

HCV full-length genome reconstruction with sequence independent amplification combined with next generation sequencing
por: Bartolini, Barbara, et al.
Publicado: (2012)

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
por: Ouwerkerk-Mahadevan, Sivi, et al.
Publicado: (2015)

Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation
por: Khemichian, Saro, et al.
Publicado: (2015)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients
por: Nardacci, Roberta, et al.
Publicado: (2014)

Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations
por: Rozera, Gabriella, et al.
Publicado: (2009)

Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study
por: Biliotti, Elisa, et al.
Publicado: (2023)

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions
por: Cimini, Eleonora, et al.
Publicado: (2015)

Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir
por: Gaetano, John N
Publicado: (2014)

Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis
por: Nguyen, Nghia H, et al.
Publicado: (2016)

Photo-induced drug eruption in a patient on combination simeprevir/sofosbuvir for hepatitis C
por: Eyre, Zachary W., et al.
Publicado: (2016)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors
por: Garbuglia, Anna Rosa, et al.
Publicado: (2016)

National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
por: Nicastri, Emanuele, et al.
Publicado: (2020)

Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections
por: Minosse, Claudia, et al.
Publicado: (2021)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mpqiel1elodkobmbe86vjmuuf6